Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Reproducibility of Fifteen Urinary Estrogens and Estrogen Metabolites over a 2-to 3-Year Period in Premenopausal Women
  2. Eliassen, A. H.; Ziegler, R. G.; Rosner, B.; Veenstra, T. D.; Roman, J. M.; Xu, X.; Hankinson, S. E.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(11): 2860-2868.
  1. 2.   Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis)
  2. Scott, L. M.; Xu, X.; Veenstra, T. D.; Tooze, J. A.; Wood, C. E.; Register, T. C.; Kock, N. D.; Cline, J. M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(10): 2594-2602.
  1. 3.   Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide
  2. Varricchio, L.; Migliaccio, A.; Castoria, G.; Yamaguchi, H.; de Falco, A.; Di Domenico, M.; Giovannelli, P.; Farrar, W.; Appella, E.; Auricchio, F.
  3. Molecular Cancer Research. 2007, Nov; 5(11): 1213-1221.
  1. 4.   Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKC delta-dependent increase in p27(Kip1) and decrease in retinoblastoma protein (pRb) phosphorylation
  2. Vucenik, I.; Ramakrishna, G.; Tantivejkul, K.; Anderson, L. M.; Ramljak, D.
  3. Breast Cancer Research and Treatment. 2005, MAY; 91(1): 35-45.
  1. 5.   The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappa B activity in drug-sensitive MCF-7 cells
  2. Brantley, E.; Patel, V.; Stinson, S. F.; Trapani, V.; Hose, C. D.; Ciolino, H. P.; Yeh, G. C.; Gutkind, J. S.; Sausville, E. A.; Loaiza-Perez, A. I.
  3. Anti-Cancer Drugs. 2005, FEB; 16(2): 137-143.
  1. 6.   Arylthioindoles, potent inhibitors of tubulin polymerization
  2. De Martino, G.; La Regina, G.; Coluccia, A.; Edler, M. C.; Barbera, M. C.; Brancale, A.; Wilcox, E.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2004, DEC 2; 47(25): 6120-6123.
  1. 7.   DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1 alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX
  2. Kaluzova, M.; Kaluz, S.; Lerman, M. I.; Stanbridge, E. J.
  3. Molecular and Cellular Biology. 2004 24(13): 5757-5766.
  1. 8.   Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Mihalic, K.; Fan, Y. X.; Xiao, W. H.; Howard, O. M. Z.; Appella, E.; Maynard, A. T.; Farrar, W. L.
  3. Nature Medicine. 2004 10(1): 40-47.
  1. 9.   The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen- activated protein kinase activity
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Mihalic, K.; Xiao, W. H.; Farrar, W. L.
  3. Cancer Research. 2003 63(9): 2046-2051.
  1. 10.   Combinatorial evolution of high-affinity peptides that bind to the Thomsen-Friedenreich carcinoma antigen
  2. Landon, L. A.; Peletskaya, E. N.; Glinsky, V. V.; Karasseva, N.; Quinn, T. P.; Deutscher, S. L.
  3. Journal of Protein Chemistry. 2003 22(2): 193-204.
  1. 11.   Hydrocarbon carcinogens induce p53 activity in normal mouse tissue (vol 173, pg 111, 2001)
  2. Stuart, D.; Khan, Q. A.; Brown, R.; Dipple, A.
  3. Cancer Letters. 2003 195(1): 121-121.
  1. 12.   Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells
  2. Khan, Q. A.; Dipple, A.; Anderson, L. M.
  3. Molecular Carcinogenesis. 2002 33(1): 1-8.
  1. 13.   Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines
  2. Khan, Q. A.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2001 173(2): 105-113.
  1. 14.   Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; Is chemoprevention against multidrug resistance possible?
  2. Ratnasinghe, D.; Daschner, P. J.; Anver, M. R.; Kasprzak, B. H.; Taylor, P. R.; Yeh, G. C.; Tangrea, J. A.
  3. Anticancer Research. 2001 21(3C): 2141-2147.
  1. 15.   Hydrocarbon carcinogens induce p53 activity in normal mouse tissue
  2. Stuart, D.; Khan, Q. A.; Brown, R.; Dipple, A.
  3. Cancer Letters. 2001 173(2): 111-114.
  1. 16.   Responsiveness to transforming growth factor-beta (TGF-beta)- mediated growth inhibition is a function of membrane-bound TGF- beta type II receptor in human breast cancer cells
  2. Lynch, M. A.; Petrel, T. A.; Song, H.; Knobloch, T. J.; Casto, B. C.; Ramljak, D.; Anderson, L. M.; DeGroff, V.; Stoner, G. D.; Brueggemeier, R. W.; Weghorst, C. M.
  3. Gene Expression. 2001 9(4-5): 157-171.
  1. 17.   Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially
  2. Ciolino, H. P.; Daschner, P. J.; Yeh, G. C.
  3. Biochemical Journal. 1999 340(Part 3): 715-722.
  1. 18.   Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells
  2. Daschner, P. J.; Ciolino, H. P.; Plouzek, C. A.; Yeh, G. C.
  3. Breast Cancer Research and Treatment. 1999 53(3): 229-240.
  1. 19.   Effect of Curcumin On the Aryl Hydrocarbon Receptor and Cytochrome P450 1a1 in Mcf-7 Human Breast Carcinoma Cells
  2. Ciolino, H. P.; Daschner, P. J.; Wang, T. T. Y.; Yeh, G. C.
  3. Biochemical Pharmacology. 1998 56(2): 197-206.
  1. 20.   Inhibition of AP-1 and NF-kappa B by manganese-containing superoxide dismutase in human breast cancer cells
  2. Li, J. J.; Oberley, L. W.; Fan, M.; Colburn, N. H.
  3. Faseb Journal. 1998 12(15): 1713-1723.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel